Cocokara Fine Incorporated operates within the Drug stores and proprietary stores sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cocokara Fine Incorporated with three other
companies in this sector in Japan:
Sugi Holdings Company Limited
sales of 457.05 billion Japanese Yen [US$4.05 billion]
of which 100%
was Drug Compounding Business),
AIN Pharmaciez Incorporation
(268.39 billion Japanese Yen [US$2.38 billion]
of which 89%
was Pharmacy Business), and
(268.21 billion Japanese Yen [US$2.38 billion]
of which 46%
was General food).
During the year ended March of 2018, sales at
Cocokara Fine Incorporated were ¥390.96 billion (US$3.46 billion).
increase of 3.6%
versus 2017, when the company's sales were ¥377.20 billion.
This was the third consecutive year of growth at Cocokara Fine Incorporated.
Sales of Drug and Dispense saw an increase
3.7% in 2018, from
¥374.79 billion to ¥388.48 billion.